- Report
- December 2025
- 379 Pages
Global
From €5155EUR$5,850USD£4,528GBP
- Report
- February 2025
- 200 Pages
Global
From €3957EUR$4,490USD£3,475GBP
- Report
- January 2025
- 429 Pages
Global
From €4362EUR$4,950USD£3,831GBP
- Report
- May 2025
- 138 Pages
Global
From €2246EUR$2,549USD£1,973GBP
€2643EUR$2,999USD£2,321GBP
- Report
- August 2025
- 149 Pages
Global
From €2246EUR$2,549USD£1,973GBP
€2643EUR$2,999USD£2,321GBP
- Report
- August 2025
- 198 Pages
Global
From €3124EUR$3,545USD£2,744GBP
€3471EUR$3,939USD£3,049GBP
- Report
- August 2025
- 182 Pages
Global
From €3124EUR$3,545USD£2,744GBP
€3471EUR$3,939USD£3,049GBP
- Report
- December 2025
- 268 Pages
Global
From €5155EUR$5,850USD£4,528GBP
- Report
- December 2025
- 189 Pages
Global
From €5155EUR$5,850USD£4,528GBP
- Report
- December 2025
- 351 Pages
Global
From €5155EUR$5,850USD£4,528GBP
- Report
- April 2025
- 250 Pages
Global
From €3957EUR$4,490USD£3,475GBP
- Report
- February 2025
- 200 Pages
Global
From €3957EUR$4,490USD£3,475GBP
- Report
- June 2025
- 400 Pages
Global
From €4361EUR$4,949USD£3,831GBP
- Report
- October 2025
- 160 Pages
Global
From €2959EUR$3,358USD£2,599GBP
€3481EUR$3,950USD£3,057GBP
- Report
- October 2025
- 160 Pages
Global
From €2959EUR$3,358USD£2,599GBP
€3481EUR$3,950USD£3,057GBP
- Report
- March 2025
- 86 Pages
Global
From €3500EUR$4,255USD£3,182GBP
- Report
- September 2025
- 140 Pages
Global
From €3633EUR$4,123USD£3,191GBP
€4274EUR$4,850USD£3,754GBP
- Report
- April 2025
- 225 Pages
Global
From €3965EUR$4,500USD£3,483GBP
- Report
- March 2025
- 140 Pages
Global
From €3633EUR$4,123USD£3,191GBP
€4274EUR$4,850USD£3,754GBP
- Report
- June 2025
- 100 Pages
United States
From €3084EUR$3,500USD£2,709GBP

The Implantable Pacemaker market is a segment of the Cardiovascular Devices industry. It consists of devices that are implanted into the body to regulate the heartbeat of patients with arrhythmia. These devices use electrical pulses to stimulate the heart muscle and maintain a regular heartbeat. Implantable pacemakers are typically used to treat bradycardia, a condition in which the heart rate is too slow.
The Implantable Pacemaker market is highly competitive, with a number of companies offering a variety of devices. These companies are focused on developing innovative technologies to improve the safety and efficacy of their products. They are also investing in research and development to create new products and expand their market share.
Some of the major companies in the Implantable Pacemaker market include Medtronic, St. Jude Medical, Boston Scientific, Biotronik, Sorin Group, and LivaNova. Show Less Read more